Pneumococcal types which exhibited varying degrees of interaction with the complement system in vitro were aerosolized into normal and decomplemented rats, and the rate of killing of pneumococci was monitored by serial cultures of whole lung homogenates. The clearance of pneumococci from the alveoli did not correlate with the ability of the pneumococci to be opsonized by complement in vitro. Similarly, rats depleted of complement in the serum and the bronchoalveolar lavage fluid maintained their ability to rapidly inactivate aerosolized pneumococci. These results indicate that the early phase of pneumococcal killing in the alveoli does not require complement and suggest that in the nonimmune host, phagocytosis by alveolar macrophages can be achieved without complementdependent opsonization or, alternatively, that extracellular factors rapidly inactivate inhaled pneumococci.
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Aerosolized bacteria are rapidly cleared from murine lungs. A small proportion of such clearance can be attributed to physical transport by the mucociliary system, but a large majority of organisms appear to be inactivated in situ (7) . The killing of gram-positive cocci in the lungs has been assumed to be mediated by phagocytes, and attempts have been made to partition the respective roles of resident alveolar macrophages and recruited polymorphonuclear leukocytes (22, 25) . In the absence of specific antibody, one would expect opsonization for phagocytosis to be mediated by the complement system. In the present study we investigated the role of complement in the pulmonary clearance of bacteria by utilizing three types of pneumococci which possess widely varying degrees of interaction with the complement system. Our data indicate that in Sprague-Dawley rats and in guinea pigs, the early clearance of pneumococci does not correlate with the degree of interaction of pneumococci with complement in vitro. In addition, pneumococcal clearance is exceptionally well preserved in the absence of an intact complement pathway. Our findings suggest that phagocytosis by macrophages in lungs may be mediated by factors other than complement and antibody or, alternatively, that bactericidal activity in the lungs may not depend entirely on killing by phagocytes.
MATERIALS AND METHODS
Animals. Sprague-Dawley male rats (Charles River Breeding Laboratories, Inc., Wilmington, Mass.) weighing 150 to 250 g were used throughout. The animals were maintained in Bioclean vertical flow units (Hazleton Systems, Cincinnati, Ohio). Adult guinea pigs were obtained from Hilltop Laboratories, Scottsdale, Pa.
Bacteria. Pneumococcal serotypes 1, 14, and 25 were obtained from the American Type Culture Collection, Rockville, Md. The bacteria were passed intraperitoneally in mice each month to maintain encapsulation. Serotypes were confirmed by the Quellung reaction, and the organisms were stored in heatinactivated (56°C for 30 min) rabbit serum at 4°C. The bacteria were taken from an overnight culture into brain heart infusion broth containing 7% heat-inactivated serum and incubated for 6 h at 37°C to achieve log-phase growth. They were then washed in phosphate-buffered saline (PBS) and brought to the desired concentration (usually 5 x 109 viable bacteria per ml) with the aid of a plot of absorbance versus viable bacterial count. The washed organisms were used promptly; however, they showed no loss of viability when stored in PBS for as long as 24 h at 4°C.
Assay for antipneumococcal antibodies. Rat sera were screened for antipneumococcal antibodies (types 1, 14, and 25 as required) by an indirect fluorescentantibody test (4) . In brief, washed, heat-killed pneumococci (10 ,u of 3 x 10i organisms per ml) were placed on Teflon-coated slides, air dried, and stored until use. The organisms were reacted successively with rat serum, an optimal dilution of rabbit anti-rat immunoglobulin G (Cappel Laboratories, Cochranville, Pa.), and an optimal dilution of fluoresceinated goat anti-rabbit immunoglobulin G (Cappel Laboratories) with two 5- 11.6 liters per min and diluted with sidestream air at 37.6 liters per min. Nebulization proceeded for 30 min with a 10-min cloud decay period before removal of the animals from the chamber. Particle size was checked with the particle sizer after 10 min of aerosolization.
After completion of the aerosol, one group of animals was sacrificed by cervical dislocation (0 h), and the remaining animals were sacrificed 30 min, 60 min, or 4 h later. The thorax of each animal was aseptically opened, and the lung parenchyma was bluntly dissected from the airways to the level of the subsegmental bronchi. The lungs were placed in glass vials with 4 ml of PBS and ground using a high-torque homogenizer (Tissumizer, Tekmar Co., Cincinnati, Ohio) for 1 min. The ground suspension was serially diluted in PBS and plated on sheep blood agar. The plates were incubated for 24 to 48 h at 37°C in 5% CO2. Plates containing 30 to 300 colonies were counted.
Statistical analysis. Data were analyzed using the Mann-Whitney test for nonparametric analysis; a probability value of less than 0.05 was considered significant.
RESULTS
Opsonic requirements of pneumococci. Three pneumococcal serotypes with differing opsonic requirements were employed. A type 1 isolate (ATCC 6301) was selected which, as reported previously (3), produces little activation of C2, C3 through C9, or the alternative complement pathway in rat serum. Based on previous studies with fluoresceinated goat anti-rat C3 (4), this isolate does not acquire C3 on its surface during incubation in rat serum, and it is not opsonized by complement as determined by a phagocytosis assay with rat peritoneal exudate cells. A type 25 pneumococcus (ATCC 6325) which activates complement exclusively through the alternative pathway in rat serum (3) was selected, and a type 14 isolate (ATCC 6314) which activates both the classical and the alternative complement pathways in rat serum (3) was chosen. These isolates give strongly positive reactions for C3 with fluoresceinated goat anti-rat C3 after incubation for 10 to 15 min in rat serum at 37°C, and both are readily opsonized by complement as determined by phagocytosis with rat peritoneal exudate cells (4) .
Antipneumococcal antibody. Antipneumococcal antibodies were not detected by fluoresceinated antibody techniques in the sera of rats used for aerosolization studies.
Decomplementation. Within 6 h after the injection of CoVF into the rats, serum C3 became undetectable. It remained undetectable for up to 36 h as indicated by the C3 protein levels measured by radial immunodiffusion and heat-labile opsonic activity measured by a phagocytosis assay (3). Sera obtained 6 to 36 h after CoVF injection were also devoid of lytic activity for rabbit erythrocytes, which is consistent with a depletion of C3 activity (3). The radial immunodiffusion and phagocytosis assays for rat C3 are able to detect 1 to 2% of the normal serum C3 level (3, 4) . Thus, the uniformly negative results for C3 which we obtained in rats treated with CoVF indicate that the rats had less than 1 to 2% of the normal serum levels of C3 at the time of the aerosolization experiments (about 20 h after injection of CoVF). As a further test of decomplementation, concentrated BALF from normal and decomplemented animals was tested in the same fashion as the serum. Functionally active C3, measured by immune adherence (1) in normal, 20-fold-concentrated BALF, was quite low (0.17% of the normal serum level), and active C3 was decreased to very low levels in BALF of CoVF-treated rats (to 0.03% of the normal serum level).
Serum C3 protein levels and functionally active C3, as determined by immune adherence, were also tested in decomplemented guinea pigs and were found to be decreased to less than 1% of the normal serum level at the time of bacterial aerosolization.
Bacterial dearance. The initial bacterial slurries contained 3 x 107 to 9 x 107 viable pneumococci per ml. During the 30-min nebulization period, 7 ml was nebulized to droplets whose mass median diameter was 4.4 ,um or less (19) . The initial deposition of bacteria is listed in Tables 1 through 3 . In no case was a significant difference noted between control and decomplemented animals in the number of bacteria deposited, and the mean deposition was similar (1 x 106 to 3 x 106) for all pneumococcal types.
Type 1 pneumococci, which show little interaction with complement in vitro, were rapidly cleared from murine lungs. Only 52% of the initial inoculum remained at 30 min in control animals, and this percentage did not differ signif- were no substantial differences in the clearance rates of the three types of pneumococci in decomplemented animals. In addition, the magnitude of clearance with each of the three pneumococcal types was impressive, equalling about half of the initial inoculum within 30 min after deposition of the bacteria. One previous study examined the effect of complement depletion on the pulmonary clearance of aerosolized pneumococci. Gross et al. (8) measured pulmonary clearance of pneumococci in mice at 4 h after deposition and noted that decomplementation decreased bacterial clearance from 91 to 75%. That study differed from the present one principally in the time period under consideration. We examined clearance during the first 30 min after deposition and detected no impairment secondary to complement depletion. However, neutrophil recruitment into the alveoli may occur within 4 h (21), and at the 4-h period, complement may be functioning more as a chemotaxin for neutrophils than as an opsonin for macrophages (P. J. Heidbrink, G. N. Gross, G. B. Toews, and A. K. Pierce, Am. Rev. Respir. Dis. 121:272,1980). The depression of clearance obtained by Gross and his colleagues was, in fact, not dramatic, possibly because chemotaxins other than those generated through the complement system were operating. A chemotactic factor distinct from complement is known to be produced by alveolar macrophages (5, 20) , and such a factor could be important in vivo. In the analogous situation of pyelonephritis caused by Escherichia coli in rats, complement depletion has little effect on either the development or the composition of the inflammatory infiltrate (27) , again suggesting the existence of chemotaxins which are independent of complement.
Pneumococcal clearance rates in the present study were rapid, but were approximately the same as the rate of pulmonary clearance previously reported for pneumococci (11, 13, 15) . Such brisk clearance cannot be mediated solely by mucociliary mechanisms, which remove aerosol-deposited bacteria at a rate of only about 10% per h (11, 14) . In our protocol, we took the precaution to dissect the lung tissue free from the major airways specifically to minimize any potential contribution of physical transport to clearance. Because of the time period studied, it is unlikely that polymorphonuclear leukocytes were involved in bacterial clearance in the present studies. Although these cells marginate in pulmonary capillaries, morphological studies indicate that recruitment into the alveoli requires at least several hours (23; Heidbrink et al., Am. Rev. Respir. Dis. 121:272, 1980). We conclude, therefore, that the killing of aerosol-deposited bacteria in the present model occurred in situ, either extracellularly or within the resident alveolar macrophages.
It is uncertain whether extracellular killing of bacteria in the alveoli contributes substantially to early bacterial clearance. This point has apparently not been evaluated for pneumococci. Alveolar lining material appears to be innocuous to staphylococci (16, 17) If the earliest phase of pneumococcal killing is indeed mediated by alveolar macrophages, one would expect opsonins to play a prominent role. The current studies were performed in rats which lacked type-specific antibodies, as judged by fluorescence techniques. It therefore seems unlikely that specific antibodies played a role in the rapid clearance that we observed. A low level of "natural" antibodies may have been present in the animals and escaped detection by fluorescent microscopy, but natural antibodies would not be expected to mediate phagocytosis of encapsulated pneumococci (9, 24) . In nonimmune hosts an intact complement system has been considered a prerequisite for effective phagocytosis of pneumococci (9, 10, 18) . How-VOL. 36, 1982 on January 5, 2018 by guest http://iai.asm.org/ Downloaded from ever, our animals were depleted of 98 to 99% of their C3. Moreover, in the course of the present studies we discovered that resident alveolar macrophages of male Sprague-Dawley rats lack detectable CR1, CR2, and CR3 receptors (Coonrod and Rehm, in press). Thus, even if C3 had been present on the pneumococci in the alveoli, the alveolar macrophages of this rat strain had no receptors through which a ligand could be formed. We further evaluated pneumococcal clearance in guinea pigs, which do have complement receptors on their alveolar macrophages, and obtained the same results as in the rats. Decomplementation did not reduce the clearance rate of pneumococci in guinea pigs, and complement did not appear to be serving as an opsonin for the removal of the organisms by phagocytes in either host.
If complement is not an opsonin for clearance of pneumococci from the lungs, how is opsonization achieved? Albumin may function as an opsonin in some situations, but Hof et al. (12) have demonstrated that alveolar macrophages do not ingest pneumococci except in the presence of a high concentration of serum albumin, which would not be attained in the alveoli. Fibronectin may similarly have an opsonic function, but its role in the alveolar microenvironment has not been delineated. Bacterial ingestion by alveolar macrophages could also be mediated through the phenomenon of surface phagocytosis, as described by Wood (28) ; this mechanism does not require prior opsonization of bacteria, relying instead upon the physical entrapment of the bacteria against alveolar walls. Finally, it should be noted that virtually all studies of opsonization and phagocytosis of pneumococci have been performed under in vitro conditions in an aqueous medium. Alveolar lining material provides a unique lipid milieu which is not easily reproduced in vitro. In such an environment, hydrophilic particles such as bacteria and phagocytes may be driven together by the forces of surface tension to provide a degree of contact sufficient to initiate phagocytosis without the necessity for conventional opsonic ligands. Alternatively, it remains possible that some extracellular factor in alveolar lining material renders pneumococci nonviable without the need for intracellular killing. The present observations call into question the traditional view that immunoglobulin-mediated or complement-mediated opsonization is a prerequisite for effective phagocytosis by alveolar macrophages in vivo.
